STOCKHOLM--(BUSINESS WIRE)--Regulatory News: With reference to the voluntary exchange offer (the “Offer”) by Vitrolife AB (publ) (“Vitrolife”) (STO:VITR) to purchase the shares in MediCult a/s (“MediCult”) (OSE:MEC), as set forth in the offer document of 3 February 2009 (the “Offer Document”), Vitrolife hereby announces an extension of the offer period under the Offer.
